Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

Updates

IVAC’s VoICE tool now has over 200 data summaries and arguments to support the broad value of vaccines

September 2018

VoICE, the Value of Immunization Compendium of Evidence, an online tool, aims to equip global advocates and partners with new arguments and evidence to demonstrate and support the continued investments in immunization programs, and why it is essential. This searchable online resource details the many far-reaching impacts of immunization and vaccine-preventable disease and on equity, […]

Bill Moss on the Increase in Measles Cases in Europe

August 2018

To talk about the increase in measles cases in some parts of the world, Dr. Bill Moss, Deputy Director of the International Vaccine Access Center, joined a program called the Show hosted by KJZZ, an NPR member station in Phoenix, Arizona.

Press Release: Rotavirus vaccine cuts infant diarrhea deaths by a third in Malawi

August 2018

A major new study has shown that rotavirus vaccination reduced infant diarrhea deaths by one-third in rural Malawi, a region with high levels of child deaths. The study led by scientists at the University of Liverpool, UCL, the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health and partners in Malawi provides […]

Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

What We Do: Project highlights

The Pneumonia Etiology Research for Child Health (PERCH) study

The Pneumonia Etiology Research for Child Health (PERCH) study is a case-control study led by IVAC that enrolled 4,232 cases and 5,325 controls between 2011-2014 at 9 sites in 7 countries (The Gambia, Mali, Kenya, Zambia, South Africa, Bangladesh and Thailand). Read More >

Rotavirus Accelerated Vaccine Introduction Network (RAVIN)

The Rotavirus Accelerated Vaccine Introduction Network (RAVIN) is a partnership led by Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), in collaboration with JSI and CDC, and is designed to provide policy, advocacy, and technical support to focus countries throughout the entire continuum of introducing rotavirus vaccine (RVV) – from the consideration and decision-making process to implementation and post-launch activities. Read More >

More Highlights